• Journal of radiological science and technology
• /
• v.43 no.5
• /
• pp.389-395
• /
• 2020

The evaluation of radioactivated components of heavy-ion accelerator facilities affects the safety of radiation management and the exposure dose for workers. and this is an important issue when predicting the disposal cost of waste during maintenance and dismantling of accelerator facilities. In this study, the FLUKA code was used to simulate the proton treatment device nozzle and classify the radio-nuclides and total radioactivity generated by each component over a short period of time. The source term was evaluated using NIST reference beam data, and the neutron flux generated for each component was calculated using the evaluated beam data. Radioactive isotopes caused by generated neutrons were compared and evaluated using nuclide information from the International Radiation Protection Association and the Korea Radioisotope association. Most of the nuclides produced form of beta rays and electron capture, and short-lived nuclides dominated. However, In the case of ⁵⁴Mn, which is a radioactive product of iron, the effect of gamma rays should be considered. In the case of tritium generated from a material with a low atomic number, it is considered that handling care should be taken due to its long half-life.

• The Korean Journal of Nuclear Medicine
• /
• v.39 no.1
• /
• pp.1-8
• /
• 2005

This paper is described on the development of KOTRON-13 and recent status of PET cyclotron by commercial cyclotron companies. KIRAMS has developed medical cyclotron which is KIRAMS-13. Samyoung Unitech produces KOTRON-13 with transfered technology by KIRAMS. As a part of Regional Cyclotron Installation Protect, KOTRON-13 cyclotrons and $[18F]FDG$ production modules are being installed at regional cyclotron centers in Korea. The medical concern with radiation technology has been growing for the last several years. Early cancer diagnosis through the cyclotron and PET-CT have been brought to public attention by commercial cyclotron models in the world. The new commercial cyclotron models are introduced compact low energy cyclotrons developed by CTI, GE, Sumitomo in recent. It produces different short-lived radioisotopes, such as $[^{18}F],\;[^{11}C],\;[^{13}N]\;and\;[^{15}O]$. For the better reliability acceleration particle is proton only. The characteristics of new model cyclotrons are changed to lower energy corresponding to less 13 MeV. New models have self-shielding and low power consumption. Design criteria for the different types of commercial cyclotrons are described with reference to hospital demands.

• Nuclear Engineering and Technology
• /
• v.53 no.4
• /
• pp.1378-1389
• /
• 2021

TRIUMF, Canada's particle accelerator centre, is constructing a new high-power ISOL (Isotope Separation On-Line) facility called ARIEL (Advanced Rare IsotopE Laboratory). Thick porous targets will be bombarded with up to 48 kW of 480 MeV protons from TRIUMF's cyclotron, or up to 100 kW of 30 MeV electrons from a new e-linac, to produce short-lived radioisotopes for a variety of applications, including nuclear astrophysics, fundamental nuclear structure and nuclear medicine. For efficient release of radioisotopes, the targets are heated to temperatures approaching 2000 ℃, and are exposed to GSv/h level radiation fields resulting from intended fissions and spallations. Due to these conditions, the operational life for each target is only about five weeks, calling for frequent remote target exchanges to limit downtime. A few days after irradiation, the targets have a residual radiation field producing a dose rate on the order of 10 Sv/h at 1 m, requiring several years of decay prior to shipment to a national disposal facility. TRIUMF is installing new remote handling infrastructure dedicated to ARIEL, including hot cells and a remote handling crane. The system design applies learnings from multiple existing facilities, including CERN-ISOLDE, GANIL-SPIRAL II as well as TRIUMF's ISAC (Isotope Separator and ACcelerator).